David Hoang's Stock Ratings

Citigroup Analyst

David Hoang is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024

Overall Average Return

3.26%

Smart Score

53.5%

Overall Average Return Percentile

42nd

Number of Ratings

27
Buy NowGet Alert
07/02/2024LBPHBuy Now
Longboard Pharmaceuticals
$35.9525.17%$40 → $45MaintainsBuyGet Alert
06/26/2024SRPTBuy Now
Sarepta Therapeutics
$145.6120.87%$172 → $176DowngradeBuy → NeutralGet Alert
06/21/2024HRMYBuy Now
Harmony Biosciences
$32.0449.81% → $48Initiates → BuyGet Alert
05/29/2024SAGEBuy Now
Sage Therapeutics
$12.39-35.43% → $8Initiates → SellGet Alert
05/10/2024XENEBuy Now
Xenon Pharmaceuticals
$42.7340.42%$62 → $60MaintainsBuyGet Alert
05/09/2024ACADBuy Now
ACADIA Pharmaceuticals
$17.7569.01%$30.19 → $30MaintainsBuyGet Alert
05/07/2024AXSMBuy Now
Axsome Therapeutics
$86.0345.3%$127 → $125MaintainsBuyGet Alert
05/03/2024NBIXBuy Now
Neurocrine Biosciences
$145.692.96%$140 → $150MaintainsNeutralGet Alert
03/26/2024AXSMBuy Now
Axsome Therapeutics
$86.0347.62%$125 → $127MaintainsBuyGet Alert
03/15/2024SLDBBuy Now
Solid Biosciences
$7.81104.87% → $16Initiates → BuyGet Alert
03/12/2024ACADBuy Now
ACADIA Pharmaceuticals
$17.7570.08%$38 → $30.19MaintainsBuyGet Alert
03/07/2024VYGRBuy Now
Voyager Therapeutics
$8.3791.16% → $16Initiates → BuyGet Alert
02/29/2024SRPTBuy Now
Sarepta Therapeutics
$145.6118.12%$160 → $172MaintainsBuyGet Alert
02/16/2024LBPHBuy Now
Longboard Pharmaceuticals
$35.9511.27% → $40Initiates → BuyGet Alert
02/08/2024NBIXBuy Now
Neurocrine Biosciences
$145.69-3.91%$141 → $140MaintainsNeutralGet Alert
01/04/2024XENEBuy Now
Xenon Pharmaceuticals
$42.7345.1% → $62Initiates → BuyGet Alert
12/13/2023DNLIBuy Now
Denali Therapeutics
$21.2050.94% → $32Initiates → BuyGet Alert
12/13/2023NBIXBuy Now
Neurocrine Biosciences
$145.69-12.83% → $127Initiates → NeutralGet Alert
12/13/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.75114.08% → $38Initiates → BuyGet Alert
12/13/2023SRPTBuy Now
Sarepta Therapeutics
$145.61-22.4% → $113Initiates → BuyGet Alert
12/13/2023AXSMBuy Now
Axsome Therapeutics
$86.0345.3% → $125Initiates → BuyGet Alert
04/26/2023ALNYBuy Now
Alnylam Pharmaceuticals
$237.83-7.5% → $220Initiates → NeutralGet Alert
04/26/2023ARWRBuy Now
Arrowhead Pharma
$28.30182.69% → $80Initiates → OutperformGet Alert
04/26/2023SRPTBuy Now
Sarepta Therapeutics
$145.6127.05% → $185Initiates → OutperformGet Alert
03/14/2023PRVBBuy Now
Provention Bio
——$15 → $25DowngradeOutperform → NeutralGet Alert
12/07/2022GOSSBuy Now
Gossamer Bio
$1.04188.46% → $3DowngradeOutperform → NeutralGet Alert
04/01/2022ORTXBuy Now
Orchard Therapeutics
———DowngradeOutperform → NeutralGet Alert